Related Articles
The PI3K/Akt inhibitor LY294002 reverses BCRP-mediated drug resistance without affecting BCRP translocation
Combination of SN-38 with gefitinib or imatinib overcomes SN-38-resistant small-cell lung cancer cells
The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance
Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells
ABCG2 expression in colorectal adenocarcinomas may predict resistance to irinotecan